Publications by authors named "Janet S Graham"

Claim this Profile
M
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.
Mark White, Megan L Mills, Laura M Millett, Kathryn Gilroy, Yourae Hong, Janet S Graham

Nature· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors.
Chara Stavraka, Athanasios Pouptsis, Alicja Synowiec, Vasileios Angelis, Liyana Satterthwaite, Janet Shirley Graham

Clin Colorectal Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
Catherine R Hanna, Sean M O'Cathail, Janet S Graham, Mark Saunders, Leslie Samuel

Radiat Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
Catherine R Hanna, Sean M O'Cathail, Janet S Graham, Mark Saunders, Leslie Samuel

Radiat Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypermutation In Pancreatic Cancer.
Jeremy L Humphris, Ann-Marie Patch, Katia Nones, Peter J Bailey, Amber L Johns, Janet S Graham

Gastroenterology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic analyses identify molecular subtypes of pancreatic cancer.
Peter Bailey, David K Chang, Katia Nones, Amber L Johns, Ann-Marie Patch, Janet S Graham

Nature· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole genomes redefine the mutational landscape of pancreatic cancer.
Nicola Waddell, Marina Pajic, Ann-Marie Patch, David K Chang, Karin S Kassahn, Janet S Graham

Nature· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel.
Asif Ali, Victoria Brown, Simon Denley, Nigel B Jamieson, Jennifer P Morton, Janet S Graham

BMC Clin Pathol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapy in colon cancer.
Janet S Graham, James Cassidy

Expert Rev Anticancer Ther· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The promises and pitfalls of epigenetic therapies in solid tumours.
Janet S Graham, Stanley B Kaye, Robert Brown

Eur J Cancer· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-centre dose-escalation and pharmacokinetic study of diflomotecan in patients with advanced malignancy.
Janet S Graham, Stephen Falk, Leslie M Samuel, Josep M Cendros, T R Jeffry Evans

Cancer Chemother Pharmacol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery).
Janet S Graham, Ruth Plummer, Candice McCoy, Kristin Kowal, Herbert Wiesinger

Eur J Cancer· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis